Telehealth Behavioral Migraine Management
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Albert Einstein College of Medicine
- Study ID
- NCT03982316
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Telehealth Behavioral Migraine Management — BEHAVIORAL1\) Weekly online modules; 2) Monthly 50 minute telephone calls; 3) 3 15-minute telephone check ins.
- Education Modules — BEHAVIORALParticipants will receive eight online weekly educational modules about migraine that will take you approximately 15 minutes to complete.
Study Details
This project aims to develop the protocol and obtain feasibility and acceptability information for Telehealth Behavioral Migraine Management in a single-arm pre-post pilot study. The investigator and study team aim to recruit 20 people with migraine from the Montefiore Headache Center in the Bronx New York. Participants will receive the 12-week protocol including a mobile app headache diary, an online patient manual with interactive vignettes, 4 50-minute telehealth sessions, and 3 15-minute check-ins.
Key Dates
- Start date
- Sep 15, 2020
- Status verified
- Feb 2026
- Primary completion
- Sep 15, 2024
- Completion
- Oct 30, 2024
Study Design
- Enrollment
- 20 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Telehealth Behavioral Migraine ManagementParticipants will receive weekly online education sessions in the following categories: Relaxation, Early Warning Signs, Triggers, Medication Adherence, Reducing Migraine Impact, Stress Management, Biofeedback, and Relapse Prevention. Participants will receive four monthly 50-minute telehealth sessions with a doctoral psychology student in a clinical health psychology program covering these topics, and three check-ins to enhance adherence to behavior change strategies. Participants will complete a daily headache diary throughout the course of treatment.
- Active Comparator: Education ModulesParticipants will receive eight online weekly educational modules about migraine that will take you approximately 15 minutes to complete in the following categories: Relaxation, Early Warning Signs, Triggers, Medication Adherence, Reducing Migraine Impact, Stress Management, \\Biofeedback, and Relapse Prevention. Participants will complete a daily headache diary throughout the course of treatment.
Primary Outcome Measure
Feasibility of TeleBMM [ Time Frame: Week 0 through Week 12 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | - |
Find similar trials in The Bronx, NY
By condition
By specialty
By research site
Related Studies
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama
- Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)PHASE3 · Enrolling By Invitation · AbbVie · Huntsville, Alabama
- Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsPHASE3 · Recruiting · Pfizer · Fort Smith, Arkansas
- A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigrainePHASE3 · Recruiting · H. Lundbeck A/S · New Haven, Connecticut